Biotech Stock Falls After Poor Test Results
La Jolla Pharmaceutical Downgraded After Report On Lupus Drug Showing

BY MARION WEBB
Senior Staff Writer

Two analysts downgraded La Jolla Pharmaceutical Co...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129